As shown in Figure 5, Lu-177-PSMA was unable to debulk tumors or decrease PSA levels in this patient, but repeated doses of Ac-225-PSMA led to complete tumor eradication and a return to normal levels of PSA. The gene discussed is FOLH1; the disease is neoplasm.